Sign up to save your podcasts
Or
Share Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder.
This Podcast is being Sponsored by LocumTenens.com
View all episodes
By American Academy of Neurology
4.7
1919 ratings
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder.
This Podcast is being Sponsored by LocumTenens.com
More shows like Neurology Today in 5
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
323 Listeners
JAMA Clinical Reviews
499 Listeners
Neurology® Podcast
296 Listeners
Practical Neurology Podcast
49 Listeners
JAMA Neurology Author Interviews
13 Listeners
Annals On Call Podcast
192 Listeners
JAMA Medical News
93 Listeners
The Clinical Problem Solvers
514 Listeners
Neurology Minute
136 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
Neurology Exam Prep Podcast
190 Listeners
The Curious Clinicians
375 Listeners
The Lancet Neurology in conversation with
6 Listeners
Continuum Audio
83 Listeners